{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:50:19Z","timestamp":1787842219473,"version":"build-2784847793"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","award":["2019.0059"],"award-info":[{"award-number":["2019.0059"]}],"id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2017-06104"],"award-info":[{"award-number":["2017-06104"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001729","name":"Stiftelsen f\u00f6r\u00a0Strategisk Forskning","doi-asserted-by":"publisher","award":["RB13-0156"],"award-info":[{"award-number":["RB13-0156"]}],"id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Rheumatoid arthritis (RA) involves several classes of pathogenic autoantibodies, some of which react with type-II collagen (COL2) in articular cartilage. We previously described a subset of COL2 antibodies targeting the F4 epitope (ERGLKGHRGFT) that could be regulatory. Here, using phage display, we developed recombinant antibodies against this epitope and examined the underlying mechanism of action. One of these antibodies, R69-4, protected against cartilage antibody- and collagen-induced arthritis in mice, but not autoimmune disease models independent of arthritogenic autoantibodies. R69-4 was further shown to cross-react with a large range of proteins within the inflamed synovial fluid, such as the complement protein C1q. Complexed R69-4 inhibited neutrophil FCGR3 signaling, thereby impairing downstream IL-1\u03b2 secretion and neutrophil self-orchestrated recruitment. Likewise, human isotypes of R69-4 protected against arthritis with comparable efficiency. We conclude that R69-4 abrogates autoantibody-mediated arthritis mainly by hindering FCGR3 signaling, highlighting its potential clinical utility in acute RA.<\/jats:p>","DOI":"10.1038\/s41467-023-41561-7","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T14:01:44Z","timestamp":1695477704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A subset of type-II collagen-binding antibodies prevents experimental arthritis by inhibiting FCGR3 signaling in neutrophils"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5178-3437","authenticated-orcid":false,"given":"Zhongwei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingze","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna L.","family":"Lundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4655-1639","authenticated-orcid":false,"given":"\u00c0lex","family":"Moreno-Gir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1526-8678","authenticated-orcid":false,"given":"Myriam","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1311-2541","authenticated-orcid":false,"given":"Erik","family":"L\u00f6nnblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4115-7904","authenticated-orcid":false,"given":"Qixing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changrong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0984-6964","authenticated-orcid":false,"given":"Lei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3468-5293","authenticated-orcid":false,"given":"Dongmei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roma","family":"Stawikowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1348-1734","authenticated-orcid":false,"given":"Anna M.","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3573-1527","authenticated-orcid":false,"given":"Gregg B.","family":"Fields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9839-2089","authenticated-orcid":false,"given":"Roman A.","family":"Zubarev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4969-2576","authenticated-orcid":false,"given":"Rikard","family":"Holmdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,23]]},"reference":[{"key":"41561_CR1","first-page":"591","volume":"18","author":"A Finckh","year":"2022","unstructured":"Finckh, A. et al. Global epidemiology of rheumatoid arthritis. Nat. Rev. Rheumatol. 18, 591\u2013602 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"41561_CR2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nri802","volume":"2","author":"M Feldmann","year":"2002","unstructured":"Feldmann, M. Development of anti-TNF therapy for rheumatoid arthritis. Nat. Rev. Immunol. 2, 364\u2013371 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"41561_CR3","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1136\/annrheumdis-2012-201918","volume":"72","author":"C Barnabe","year":"2013","unstructured":"Barnabe, C. et al. Healthcare service utilisation costs are reduced when rheumatoid arthritis patients achieve sustained remission. Ann. Rheum. Dis. 72, 1664\u20131668 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"41561_CR4","doi-asserted-by":"crossref","DOI":"10.1186\/s41927-019-0054-y","volume":"3","author":"NJ Gullick","year":"2019","unstructured":"Gullick, N. J. et al. Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis. BMC Rheumatol. 3, 6 (2019).","journal-title":"BMC Rheumatol."},{"key":"41561_CR5","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","volume":"295","author":"T Bongartz","year":"2006","unstructured":"Bongartz, T. et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. Jama 295, 2275\u20132285 (2006).","journal-title":"Jama"},{"key":"41561_CR6","doi-asserted-by":"crossref","unstructured":"Boman, A. et al. Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study. RMD Open 5, e000946 (2019).","DOI":"10.1136\/rmdopen-2019-000946"},{"key":"41561_CR7","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/art.10472","volume":"46","author":"H Burkhardt","year":"2002","unstructured":"Burkhardt, H. et al. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. Arthritis Rheum. 46, 2339\u20132348 (2002).","journal-title":"Arthritis Rheum."},{"key":"41561_CR8","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/nprot.2006.393","volume":"1","author":"LM Khachigian","year":"2006","unstructured":"Khachigian, L. M. Collagen antibody-induced arthritis. Nat. Protoc. 1, 2512\u20132516 (2006).","journal-title":"Nat. Protoc."},{"key":"41561_CR9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1074-7613(02)00275-3","volume":"16","author":"H Ji","year":"2002","unstructured":"Ji, H. et al. Arthritis critically dependent on innate immune system players. Immunity 16, 157\u2013168 (2002).","journal-title":"Immunity"},{"key":"41561_CR10","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4049\/jimmunol.1102310","volume":"188","author":"NK Banda","year":"2012","unstructured":"Banda, N. K. et al. Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice. J. Immunol. 188, 1469\u20131478 (2012).","journal-title":"J. Immunol."},{"key":"41561_CR11","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0002-9440(10)63543-2","volume":"163","author":"P van Lent","year":"2003","unstructured":"van Lent, P. et al. The inhibitory receptor FcgammaRII reduces joint inflammation and destruction in experimental immune complex-mediated arthritides not only by inhibition of FcgammaRI\/III but also by efficient clearance and endocytosis of immune complexes. Am. J. Pathol. 163, 1839\u20131848 (2003).","journal-title":"Am. J. Pathol."},{"key":"41561_CR12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1365-2249.2001.01459.x","volume":"123","author":"JT Nash","year":"2001","unstructured":"Nash, J. T. et al. Immune complex processing in C1q-deficient mice. Clin. Exp. Immunol. 123, 196\u2013202 (2001).","journal-title":"Clin. Exp. Immunol."},{"key":"41561_CR13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/19420862.2017.1323159","volume":"9","author":"G Dekkers","year":"2017","unstructured":"Dekkers, G. et al. Affinity of human IgG subclasses to mouse Fc gamma receptors. mAbs 9, 767\u2013773 (2017).","journal-title":"mAbs"},{"key":"41561_CR14","doi-asserted-by":"crossref","first-page":"R544","DOI":"10.1186\/ar1217","volume":"6","author":"KS Nandakumar","year":"2004","unstructured":"Nandakumar, K. S., B\u00e4cklund, J., Vestberg, M. & Holmdahl, R. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells. Arthritis Res. Ther. 6, R544\u2013R550 (2004).","journal-title":"Arthritis Res. Ther."},{"key":"41561_CR15","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.ajpath.2013.06.019","volume":"183","author":"A Pizzolla","year":"2013","unstructured":"Pizzolla, A., Wing, K. & Holmdahl, R. A glucose-6-phosphate isomerase peptide induces T and B cell-dependent chronic arthritis in C57BL\/10 mice: arthritis without reactive oxygen species and complement. Am. J. Pathol. 183, 1144\u20131155 (2013).","journal-title":"Am. J. Pathol."},{"key":"41561_CR16","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-9-209","volume":"9","author":"M Benkhoucha","year":"2012","unstructured":"Benkhoucha, M. et al. IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis. J. Neuroinflammation 9, 209 (2012).","journal-title":"J. Neuroinflammation"},{"key":"41561_CR17","doi-asserted-by":"crossref","first-page":"E3669","DOI":"10.1073\/pnas.1405798111","volume":"111","author":"I Khmaladze","year":"2014","unstructured":"Khmaladze, I. et al. Mannan induces ROS-regulated, IL-17A-dependent psoriasis arthritis-like disease in mice. Proc. Natl Acad. Sci. USA 111, E3669\u2013E3678 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"41561_CR18","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.4049\/jimmunol.1003780","volume":"187","author":"DA Patel","year":"2011","unstructured":"Patel, D. A. et al. Neonatal Fc receptor blockade by Fc engineering ameliorates arthritis in a murine model. J. Immunol. 187, 1015\u20131022 (2011).","journal-title":"J. Immunol."},{"key":"41561_CR19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/art.23049","volume":"58","author":"KS Nandakumar","year":"2008","unstructured":"Nandakumar, K. S. et al. Arthritogenic antibodies specific for a major type II collagen triple-helical epitope bind and destabilize cartilage independent of inflammation. Arthritis Rheum. 58, 184\u2013196 (2008).","journal-title":"Arthritis Rheum."},{"key":"41561_CR20","first-page":"312","volume":"622","author":"AJ Fosang","year":"2010","unstructured":"Fosang, A. J. et al. Neoepitope antibodies against MMP-cleaved and aggrecanase-cleaved aggrecan. Methods Mol. Biol. 622, 312\u2013347 (2010).","journal-title":"Methods Mol. Biol."},{"key":"41561_CR21","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/annrheumdis-2019-216911","volume":"79","author":"G Wang","year":"2020","unstructured":"Wang, G. et al. TGF\u03b2 attenuates cartilage extracellular matrix degradation via enhancing FBXO6-mediated MMP14 ubiquitination. Ann. Rheum. Dis. 79, 1111\u20131120 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"41561_CR22","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0002-9440(10)63542-0","volume":"163","author":"KS Nandakumar","year":"2003","unstructured":"Nandakumar, K. S., Svensson, L. & Holmdahl, R. Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am. J. Pathol. 163, 1827\u20131837 (2003).","journal-title":"Am. J. Pathol."},{"key":"41561_CR23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.immuni.2010.07.018","volume":"33","author":"RC Chou","year":"2010","unstructured":"Chou, R. C. et al. Lipid-cytokine-chemokine cascade drives neutrophil recruitment in a murine model of inflammatory arthritis. Immunity 33, 266\u2013278 (2010).","journal-title":"Immunity"},{"key":"41561_CR24","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/JID.2015.410","volume":"136","author":"JL Li","year":"2016","unstructured":"Li, J. L. et al. Neutrophils self-regulate immune complex-mediated cutaneous inflammation through CXCL2. J. Invest. Dermatol. 136, 416\u2013424 (2016).","journal-title":"J. Invest. Dermatol."},{"key":"41561_CR25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1074-7613(03)00263-2","volume":"19","author":"C Martin","year":"2003","unstructured":"Martin, C. et al. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity 19, 583\u2013593 (2003).","journal-title":"Immunity"},{"key":"41561_CR26","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1182\/blood-2013-06-510875","volume":"123","author":"LT Weckbach","year":"2014","unstructured":"Weckbach, L. T. et al. The cytokine midkine supports neutrophil trafficking during acute inflammation by promoting adhesion via \u03b22 integrins (CD11\/CD18). Blood 123, 1887\u20131896 (2014).","journal-title":"Blood"},{"key":"41561_CR27","doi-asserted-by":"crossref","first-page":"E3177","DOI":"10.1073\/pnas.1213797109","volume":"109","author":"CD Sadik","year":"2012","unstructured":"Sadik, C. D., Kim, N. D., Iwakura, Y. & Luster, A. D. Neutrophils orchestrate their own recruitment in murine arthritis through C5aR and Fc\u03b3R signaling. Proc. Natl Acad. Sci. USA 109, E3177\u2013E3185 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"41561_CR28","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.4049\/jimmunol.153.3.1254","volume":"153","author":"I Dransfield","year":"1994","unstructured":"Dransfield, I. et al. Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression. J. Immunol. 153, 1254\u20131263 (1994).","journal-title":"J. Immunol."},{"key":"41561_CR29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fimmu.2013.00060","volume":"4","author":"D El Kebir","year":"2013","unstructured":"El Kebir, D. & Filep, J. G. Modulation of neutrophil apoptosis and the resolution of inflammation through \u03b22 integrins. Front. Immunol. 4, 60 (2013).","journal-title":"Front. Immunol."},{"key":"41561_CR30","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/eji.202048605","volume":"51","author":"D Vaartjes","year":"2021","unstructured":"Vaartjes, D. et al. Genetic dissection of a major haplotype associated with arthritis reveal Fc\u03b3R2b and Fc\u03b3R3 to act additively. Eur. J. Immunol. 51, 682\u2013693 (2021).","journal-title":"Eur. J. Immunol."},{"key":"41561_CR31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1084\/jem.20081859","volume":"206","author":"Z Jakus","year":"2009","unstructured":"Jakus, Z., Simon, E., Frommhold, D., Sperandio, M. & M\u00f3csai, A. Critical role of phospholipase Cgamma2 in integrin and Fc receptor-mediated neutrophil functions and the effector phase of autoimmune arthritis. J. Exp. Med. 206, 577\u2013593 (2009).","journal-title":"J. Exp. Med."},{"key":"41561_CR32","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1172\/JCI115882","volume":"90","author":"MF Tosi","year":"1992","unstructured":"Tosi, M. F. & Zakem, H. Surface expression of Fc gamma receptor III (CD16) on chemoattractant-stimulated neutrophils is determined by both surface shedding and translocation from intracellular storage compartments. J. Clin. Investig. 90, 462\u2013470 (1992).","journal-title":"J. Clin. Investig."},{"key":"41561_CR33","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1074\/jbc.M116.767749","volume":"292","author":"M Lo","year":"2017","unstructured":"Lo, M. et al. Effector-attenuating substitutions that maintain antibody stability and reduce toxicity in mice. J. Biol. Chem. 292, 3900\u20133908 (2017).","journal-title":"J. Biol. Chem."},{"key":"41561_CR34","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7637","volume":"6","author":"T Negishi-Koga","year":"2015","unstructured":"Negishi-Koga, T. et al. Immune complexes regulate bone metabolism through FcR\u03b3 signalling. Nat. Commun. 6, 6637 (2015).","journal-title":"Nat. Commun."},{"key":"41561_CR35","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nrrheum.2010.56","volume":"6","author":"MC Pickering","year":"2010","unstructured":"Pickering, M. C. & Botto, M. Are anti-C1q antibodies different from other SLE autoantibodies? Nat. Rev. Rheumatol. 6, 490\u2013493 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"41561_CR36","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.4049\/jimmunol.179.6.4101","volume":"179","author":"NK Banda","year":"2007","unstructured":"Banda, N. K., Takahashi, K., Wood, A. K., Holers, V. M. & Arend, W. P. Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative pathway. J. Immunol. 179, 4101\u20134109 (2007).","journal-title":"J. Immunol."},{"key":"41561_CR37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.immuni.2010.08.006","volume":"33","author":"B McDonald","year":"2010","unstructured":"McDonald, B. & Kubes, P. Chemokines: sirens of neutrophil recruitment-but is it just one song? Immunity 33, 148\u2013149 (2010).","journal-title":"Immunity"},{"key":"41561_CR38","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1002\/eji.200939884","volume":"39","author":"SN Syed","year":"2009","unstructured":"Syed, S. N. et al. Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a. Eur. J. Immunol. 39, 3343\u20133356 (2009).","journal-title":"Eur. J. Immunol."},{"key":"41561_CR39","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nmeth.3322","volume":"12","author":"A Hasenberg","year":"2015","unstructured":"Hasenberg, A. et al. Catchup: a mouse model for imaging-based tracking and modulation of neutrophil granulocytes. Nat. Methods 12, 445\u2013452 (2015).","journal-title":"Nat. Methods"},{"key":"41561_CR40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/ard.61.1.13","volume":"61","author":"G Fossati","year":"2002","unstructured":"Fossati, G., Bucknall, R. C. & Edwards, S. W. Insoluble and soluble immune complexes activate neutrophils by distinct activation mechanisms: changes in functional responses induced by priming with cytokines. Ann. Rheum. Dis. 61, 13\u201319 (2002).","journal-title":"Ann. Rheum. Dis."},{"key":"41561_CR41","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3389\/fimmu.2019.01297","volume":"10","author":"J Lejeune","year":"2019","unstructured":"Lejeune, J., Brachet, G. & Watier, H. Evolutionary story of the low\/medium-affinity IgG Fc receptor gene cluster. Front. Immunol. 10, 1297 (2019).","journal-title":"Front. Immunol."},{"key":"41561_CR42","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.autrev.2016.02.006","volume":"15","author":"X Yu","year":"2016","unstructured":"Yu, X. & Lazarus, A. H. Targeting Fc\u03b3Rs to treat antibody-dependent autoimmunity. Autoimmun. Rev. 15, 510\u2013512 (2016).","journal-title":"Autoimmun. Rev."},{"key":"41561_CR43","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/art.22353","volume":"55","author":"A Finckh","year":"2006","unstructured":"Finckh, A., Liang, M. H., van Herckenrode, C. M. & de Pablo, P. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis. Arthritis Rheum. 55, 864\u2013872 (2006).","journal-title":"Arthritis Rheum."},{"key":"41561_CR44","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/art.22718","volume":"56","author":"AE van der Bijl","year":"2007","unstructured":"van der Bijl, A. E. et al. Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis. Arthritis Rheum. 56, 2129\u20132134 (2007).","journal-title":"Arthritis Rheum."},{"key":"41561_CR45","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00296-010-1526-y","volume":"31","author":"YH Lee","year":"2011","unstructured":"Lee, Y. H., Bae, S. C. & Song, G. G. The efficacy and safety of rituximab for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials. Rheumatol. Int. 31, 1493\u20131499 (2011).","journal-title":"Rheumatol. Int."},{"key":"41561_CR46","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/eji.201444486","volume":"44","author":"R Holmdahl","year":"2014","unstructured":"Holmdahl, R., Malmstr\u00f6m, V. & Burkhardt, H. Autoimmune priming, tissue attack and chronic inflammation - the three stages of rheumatoid arthritis. Eur. J. Immunol. 44, 1593\u20131599 (2014).","journal-title":"Eur. J. Immunol."},{"key":"41561_CR47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41590-020-00816-x","volume":"22","author":"CM Weyand","year":"2021","unstructured":"Weyand, C. M. & Goronzy, J. J. The immunology of rheumatoid arthritis. Nat. Immunol. 22, 10\u201318 (2021).","journal-title":"Nat. Immunol."},{"key":"41561_CR48","doi-asserted-by":"crossref","unstructured":"Ge, C. et al. Anti-citrullinated protein antibodies cause arthritis by cross-reactivity to joint cartilage. JCI insight 2, e93688 (2017).","DOI":"10.1172\/jci.insight.93688"},{"key":"41561_CR49","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/379346a0","volume":"379","author":"T Takai","year":"1996","unstructured":"Takai, T., Ono, M., Hikida, M., Ohmori, H. & Ravetch, J. V. Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature 379, 346\u2013349 (1996).","journal-title":"Nature"},{"key":"41561_CR50","doi-asserted-by":"crossref","first-page":"12646","DOI":"10.1073\/pnas.0403831101","volume":"101","author":"M Hultqvist","year":"2004","unstructured":"Hultqvist, M. et al. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc. Natl Acad. Sci. USA 101, 12646\u201312651 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"41561_CR51","doi-asserted-by":"crossref","first-page":"A60","DOI":"10.1136\/annrheumdis-2011-201236.23","volume":"71","author":"D Klaczkowska","year":"2012","unstructured":"Klaczkowska, D., Ekman, D., Holmdahl, R. & Nandakumar, K. S. Identification of arthritis promoting non-obese diabetic genes in the Cia9 locus using different genetic strategies. Ann. Rheum. Dis. 71, A60\u2013A60 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"41561_CR52","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/art.37805","volume":"65","author":"AM Croxford","year":"2013","unstructured":"Croxford, A. M. et al. Type II collagen-specific antibodies induce cartilage damage in mice independent of inflammation. Arthritis Rheum. 65, 650\u2013659 (2013).","journal-title":"Arthritis Rheum."},{"key":"41561_CR53","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M. & Altman, D. G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 8, e1000412 (2010).","journal-title":"PLoS Biol."},{"key":"41561_CR54","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/ar2089","volume":"8","author":"KS Nandakumar","year":"2006","unstructured":"Nandakumar, K. S. & Holmdahl, R. Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis. Arthritis Res. Ther. 8, 223 (2006).","journal-title":"Arthritis Res. Ther."},{"key":"41561_CR55","doi-asserted-by":"crossref","first-page":"R130","DOI":"10.1186\/ar2545","volume":"10","author":"K Iwanami","year":"2008","unstructured":"Iwanami, K. et al. Arthritogenic T cell epitope in glucose-6-phosphate isomerase-induced arthritis. Arthritis Res. Ther. 10, R130 (2008).","journal-title":"Arthritis Res. Ther."},{"key":"41561_CR56","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jid.2021.01.006","volume":"141","author":"J Zhong","year":"2021","unstructured":"Zhong, J., Li, Q. & Holmdahl, R. Natural loss-of-function mutations in Qa2 and NCF1 cause the spread of mannan-induced psoriasis. J. Invest. Dermatol. 141, 1765\u20131771.e1764 (2021).","journal-title":"J. Invest. Dermatol."},{"key":"41561_CR57","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joca.2004.11.008","volume":"13","author":"C Salvat","year":"2005","unstructured":"Salvat, C., Pigenet, A., Humbert, L., Berenbaum, F. & Thirion, S. Immature murine articular chondrocytes in primary culture: a new tool for investigating cartilage. Osteoarthr. Cartil. 13, 243\u2013249 (2005).","journal-title":"Osteoarthr. Cartil."},{"key":"41561_CR58","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367\u20131372 (2008).","journal-title":"Nat. Biotechnol."},{"key":"41561_CR59","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/nprot.2012.138","volume":"7","author":"FY Avci","year":"2012","unstructured":"Avci, F. Y., Li, X., Tsuji, M. & Kasper, D. L. Isolation of carbohydrate-specific CD4(+) T cell clones from mice after stimulation by two model glycoconjugate vaccines. Nat. Protoc. 7, 2180\u20132192 (2012).","journal-title":"Nat. Protoc."},{"key":"41561_CR60","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/art.42463","volume":"75","author":"E L\u00f6nnblom","year":"2023","unstructured":"L\u00f6nnblom, E. et al. Autoantibodies to disease-related proteins in joints as novel biomarkers for the diagnosis of rheumatoid arthritis. Arthritis Rheumatol. 75, 1110\u20131119 (2023).","journal-title":"Arthritis Rheumatol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-41561-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-41561-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-41561-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T14:40:16Z","timestamp":1700145616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-41561-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,23]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["41561"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-41561-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,23]]},"assertion":[{"value":"17 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.H. is the founder of Vacara AB. Z.X. and E.L. are partially employees of Vacara AB. Other authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5949"}}